Clinical Trials
-
ERNA-101 Platform Targets Cancer with Differentiated Therapy
NEW YORK, July 15 — A new targeted cancer therapy platform is moving toward its first human trials, offering a potential advance…
-
Ernexa Plans IND Filing in Q3 and Ovarian Cancer Trial in Q4 2026
NEW YORK, July 15 — Ernexa Therapeutics is moving its lead candidate ERNA-101 toward a first-in-human Phase 1 study, with the trial…
-
Ernexa Therapeutics Advances ERNA-101 to First-in-Human Trial Planning
SINGAPORE, July 15 — A new cancer therapy candidate is taking its first step from the laboratory bench toward the bedside, with…
-
Akeso gets FDA and China clearance for Phase II cadonilimab liver cancer trial
BEIJING, July 15 — Akeso’s experimental cancer drug cadonilimab is now being studied in a Phase II clinical trial in the United…
-
Akeso starts US Phase II cadonilimab trial in gastric cancer with Memorial Sloan Kettering
ISLAMABAD, July 15 — Akeso, the Chinese biopharmaceutical company, has advanced its investigational drug cadonilimab into a Phase II clinical trial in…
-
Next-Generation CAR T-Cell Therapies Aim at Solid Tumors and Off-the-Shelf Donor Cells
SAN FRANCISCO, July 14 — The next generation of cancer immunotherapy is racing toward a milestone that could change how thousands of…
-
New Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Trial
WASHINGTON, July 14 — For the millions of American families watching a loved one slowly lose their memories, the arrival of lecanemab…
-
HDT Bio Takes Glioblastoma Immunotherapy HDT-401 Toward a Phase 1 Trial at McGill
MONTREAL, July 13 — McGill University has announced a new partnership with HDT Bio, a biotechnology firm, to advance clinical trials for…
-
Alzheimer’s Drug Lecanemab Slows Cognitive Decline 27% in Trial
MANILA, July 10 — For millions of families across Asia and around the world, the shadow of Alzheimer’s disease has long been…
-
Metformin and Rapamycin: Two Anti-Aging Drug Candidates With Very Different Evidence
NEW YORK, July 8 — The calculus around aging research is shifting. Two drugs, one a decades-old diabetes staple and the other…
-
Strengthening Alberta’s Clinical Trial Infrastructure with New Funding
EDMONTON, July 7 — A significant investment in clinical trials is set to transform cancer care in Alberta, with the Alberta Cancer…
-
Alberta Cancer Foundation Commits $35 Million to Cancer Clinical Trials
EDMONTON, July 7 — Wendy Beauchesne has spent the last six years at the helm of the Alberta Cancer Foundation, and on…
-
Owerko Centre Among Sites Sharing Alberta Cancer Foundation’s $35M Trials Fund
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
-
UK Phase 2 Trial Opens to Test CY-101 in Rare Adrenal Cancer
LONDON, July 5 — A new immunotherapy drug is entering clinical trials for patients with a rare and aggressive adrenal gland cancer…
-
Tata Memorial Papaya Leaf Extract Trial Faces Journal Concern Over Platelet Results
MUMBAI, July 3 — A new Phase III randomised clinical trial from Tata Memorial Centre’s GI medical oncology department has validated the…
-
Vitamin B12 compound shows promise against deadly brain cancer
BOSTON — A modified form of vitamin B12, designed to deliver nitric oxide directly to tumors, has shown promise in early animal…
-
Zenocutuzumab Gives Rare NRG1-Positive Bile Duct Cancer Patients a First Targeted Option
For the small group of patients whose bile duct cancer is driven by a specific genetic glitch, the standard treatment has been…
-
NIH says All of Us is now the world’s largest integrated health database
NEW YORK, July 1 — 747,000 participants. That is the headline number for the National Institutes of Health’s All of Us research…
-
USC study finds fish oil reaches brain but fails to boost cognition in older adults
LOS ANGELES — The omega-3s got to the brain. They just didn’t do anything once they got there. That is the finding…
-
Anixa Biosciences Secures First Korean Patent for Breast Cancer Vaccine
Anixa’s Korean Patent Opens Door to Clinical Trials in Asia SAN JOSE — The patent paperwork is done. Now comes the hard…
-
Ipsen completes Kartos acquisition and adds navtemadlin to its myelofibrosis pipeline
The clinical trial is called POIESIS. More than 600 patients. Over 250 sites worldwide. It is testing navtemadlin as an add-on to…
-
FDA Clears First Human Trial of Partial Epigenetic Reprogramming for Eye Disease
BOSTON, June 11 — Life Biosciences, a Boston-based longevity company, has started the first FDA-approved human clinical trial to turn back time…
-
New Drug Targets ‘Undruggable’ KRAS in Pancreatic Cancer
For many years the KRAS gene was regarded as an impossible target for drug development. Its surface lacks distinct pockets, giving medicinal…
-
Columbia and Tübingen Researchers Find Protein NFIL3 Drives CAR T-Cell Exhaustion
Engineered immune cells known as CAR‑T cells have revolutionized treatment for blood cancers, yet their impact on solid tumors such as breast,…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992